The Molecular Oncology Resource is an essential component of our JHU ICMIC as it will provide: (i) a centralized resource for production of reagents and constructs, as well as expertise in molecular biology, (ii) a centralized resource for human cancer cell lines including cell lines constructed to report on hypoxia or with knockdown or overexpression of molecular pathways, (iii) clinical specimens to study in the research projects, (iv) expertise and guidance in immunostaining, molecular pathology characterization of archived or biopsied clinical and preclinical tissues obtained in the research components, (v) veterinary expertise and guidance for the vertebrate animal studies, and (vi) expert guidance in clinical translation. Experts in integrating molecular biology for molecular imaging (Dr. Raman, co-director), molecular biology (Dr. Sukumar), lentiviral vectors (Dr. Krishnamachary), vertebrate animal pathology and veterinary expertise (Dr. Gabrielson), pathology (Dr. Argani), and clinical translation (Dr. Jaffee) will form this resource. They will work closely with the JHU ICMIC investigators in experimental design and implementation of preclinical studies, use of human tissues and interpretation of data obtained using human tissues, molecular characterization of cells and tumor tissue, and the creation of novel reagents and constructs to advance the goals of the JHU ICMIC Program. We have restructured this resource to include Dr. Elizabeth Jaffee, the Associate Director for Translational Research at the Sidney Kimmel Cancer Center at Johns Hopkins. As Co-Director of this resource. Dr. Jaffee will provide expertise and guidance in clinical translation studies. This resource will provide the necessary infrastructure and support for molecular biology, pathology, and translational oncology for the four research components, the current and future developmental projects, and the research project of each career development trainee.
The Molecular Oncology Resource will provide the infrastructure for JHU ICMIC studies that require expertise and assistance in molecular biology, pathology, veterinary medicine, and clinical translation.
|Winnard Jr, Paul T; Bharti, Santosh K; Penet, Marie-France et al. (2016) Detection of Pancreatic Cancer-Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance. Cancer Res 76:1441-50|
|Chan, Kannie W Y; Jiang, Lu; Cheng, Menglin et al. (2016) CEST-MRI detects metabolite levels altered by breast cancer cell aggressiveness and chemotherapy response. NMR Biomed 29:806-16|
|Azad, Babak Behnam; Chatterjee, Samit; Lesniak, Wojciech G et al. (2016) A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts. Oncotarget 7:12344-58|
|Penet, Marie-France; Chen, Zhihang; Mori, Noriko et al. (2016) Magnetic Resonance Spectroscopy of siRNA-Based Cancer Therapy. Methods Mol Biol 1372:37-47|
|Xu, Xiang; Yadav, Nirbhay N; Zeng, Haifeng et al. (2016) Magnetization transfer contrast-suppressed imaging of amide proton transfer and relayed nuclear overhauser enhancement chemical exchange saturation transfer effects in the human brain at 7T. Magn Reson Med 75:88-96|
|Mascini, Nadine E; Cheng, Menglin; Jiang, Lu et al. (2016) Mass Spectrometry Imaging of the Hypoxia Marker Pimonidazole in a Breast Tumor Model. Anal Chem 88:3107-14|
|Chatterjee, Samit; Lesniak, Wojciech G; Gabrielson, Matthew et al. (2016) A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors. Oncotarget 7:10215-27|
|Penet, Marie-France; Kakkad, Samata; Pathak, Arvind P et al. (2016) Structure and Function of a Prostate Cancer Dissemination Permissive Extracellular Matrix. Clin Cancer Res :|
|Lesniak, Wojciech G; Oskolkov, Nikita; Song, Xiaolei et al. (2016) Salicylic Acid Conjugated Dendrimers Are a Tunable, High Performance CEST MRI NanoPlatform. Nano Lett 16:2248-53|
|Behnam Azad, Babak; Lisok, Ala; Chatterjee, Samit et al. (2016) Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts. J Nucl Med 57:981-8|
Showing the most recent 10 out of 198 publications